← Back to guidelines
Cardiology616 papers

Arthritis mutilans

Last edited: 4/14/2026

Overview

Arthritis mutilans, also known as acrosyndactyly or mutilating rheumatoid arthritis, is a severe, deforming form of rheumatoid arthritis characterized by progressive joint destruction, resorption of bone, and functional disability, primarily affecting the hands and feet. 9

Diagnosis

  • Radiographic findings showing characteristic bone resorption and joint deformities.
  • Clinical presentation with severe joint deformities, functional impairment, and often a history of long-standing rheumatoid arthritis.
  • No specific laboratory tests; diagnosis is primarily clinical and radiographic. 9
  • Management

  • First-line treatments: Early aggressive management of rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. 4
  • Adjunctive treatments: Physical therapy focusing on maintaining joint function and preventing contractures. 4
  • Surgical interventions: Considered for severe deformities to improve function and cosmesis, though specific protocols are not detailed in provided abstracts. 7
  • Special Populations

  • Elderly: Management focuses on minimizing functional decline and pain management, with careful consideration of polypharmacy impacts on surgical outcomes. 2
  • Comorbidities: Patients with comorbidities requiring extensive perioperative care may benefit from enhanced perioperative surgical home models to improve outcomes. 3
  • Key Recommendations

  • Early initiation of DMARDs to control rheumatoid arthritis and potentially mitigate progression to arthritis mutilans. (Evidence: Moderate 4)
  • Implement comprehensive physical therapy programs to preserve joint function and mobility in affected individuals. (Evidence: Expert opinion 4)
  • For severe cases, multidisciplinary surgical approaches may be considered to address deformities, though evidence is limited and primarily based on expert consensus. (Evidence: Expert opinion 7)
  • References

    1 Peel TN, Astbury S, Cheng AC, Paterson DL, Buising KL, Spelman T et al.. Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty. The New England journal of medicine 2023. link 2 Rasmussen NB, Kehlet H, Knudsen TB, Printzlau P, Jørgensen CC. Preoperative prescriptions and polypharmacy in elective total hip and knee arthroplasty from 2010 to 2017, a descriptive cohort study. Acta anaesthesiologica Scandinavica 2023. link 3 Wyles CC, Abdel MP, Amundson AW, Duncan CM, Pepper MB, Ingalls LA et al.. Orthopedic Surgery and Anesthesiology Surgical Improvement Strategies Project-Phase II Outcomes. The Journal of arthroplasty 2021. link 4 Jette DU, Hunter SJ, Burkett L, Langham B, Logerstedt DS, Piuzzi NS et al.. Physical Therapist Management of Total Knee Arthroplasty. Physical therapy 2020. link 5 Özkan D, Akkaya T, Yalcindag A, Hanci T, Gönen E, Gümüs H et al.. Propofol sedation in total knee replacement : effects on oxidative stress and ischemia-reperfusion damage. Der Anaesthesist 2013. link 6 Labek G, Stoica CI, Böhler N. Comparison of the information in arthroplasty registers from different countries. The Journal of bone and joint surgery. British volume 2008. link 7 Collins CP, Wilson KJ, Collins PC. Lateral pterygoid myotomy with reattachment to the condylar neck: an adjunct to restore function after total joint reconstruction. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2003. link 8 Dalén T, Engström KG. Filterability of autotransfusion blood cells and plasma after total knee arthroplasty. Clinical hemorheology and microcirculation 1998. link 9 O'Neill TW, Evison G, Bhalla AK. Pseudoarthroplastic' hand in arthritis mutilans. British journal of rheumatology 1992. link

    Original source

    1. [1]
      Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.Peel TN, Astbury S, Cheng AC, Paterson DL, Buising KL, Spelman T et al. The New England journal of medicine (2023)
    2. [2]
      Preoperative prescriptions and polypharmacy in elective total hip and knee arthroplasty from 2010 to 2017, a descriptive cohort study.Rasmussen NB, Kehlet H, Knudsen TB, Printzlau P, Jørgensen CC Acta anaesthesiologica Scandinavica (2023)
    3. [3]
      Orthopedic Surgery and Anesthesiology Surgical Improvement Strategies Project-Phase II Outcomes.Wyles CC, Abdel MP, Amundson AW, Duncan CM, Pepper MB, Ingalls LA et al. The Journal of arthroplasty (2021)
    4. [4]
      Physical Therapist Management of Total Knee Arthroplasty.Jette DU, Hunter SJ, Burkett L, Langham B, Logerstedt DS, Piuzzi NS et al. Physical therapy (2020)
    5. [5]
      Propofol sedation in total knee replacement : effects on oxidative stress and ischemia-reperfusion damage.Özkan D, Akkaya T, Yalcindag A, Hanci T, Gönen E, Gümüs H et al. Der Anaesthesist (2013)
    6. [6]
      Comparison of the information in arthroplasty registers from different countries.Labek G, Stoica CI, Böhler N The Journal of bone and joint surgery. British volume (2008)
    7. [7]
      Lateral pterygoid myotomy with reattachment to the condylar neck: an adjunct to restore function after total joint reconstruction.Collins CP, Wilson KJ, Collins PC Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics (2003)
    8. [8]
      Filterability of autotransfusion blood cells and plasma after total knee arthroplasty.Dalén T, Engström KG Clinical hemorheology and microcirculation (1998)
    9. [9]
      Pseudoarthroplastic' hand in arthritis mutilans.O'Neill TW, Evison G, Bhalla AK British journal of rheumatology (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG